TribLIVE

| Home


Weather Forecast
 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

 

 
 


Show commenting policy

Most-Read Stories

  1. Steelers use 3 late first-half TDs to stun Texans
  2. Rossi: Steelers’ season all about going big
  3. Rookie Bryant sparks deep passing game for Steelers in victory
  4. Kin of 2013 DUI crash victim in Hempfield lose young family in fire
  5. Harrison woman dead in 3-car crash in Natrona Heights
  6. Steelers notebook: Adams replaces concussed Gilbert
  7. Bortuzzo could provide much-needed physical presence for Penguins
  8. For all but 2 minutes vs. Steelers, Texans played ‘pretty good game’
  9. DNA evidence in alleged June 2013 rape leads to Latrobe man’s arrest
  10. Pa. Supreme Court Justice McCaffery suspended in email porn scandal
  11. Ferrante defense says arrest of prosecutor’s boyfriend could affect case
Subscribe today! Click here for our subscription offers.